+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In-Vitro Toxicology Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • PDF Icon

    Report

  • 111 Pages
  • November 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5916098
Description Jump to:
The in-vitro toxicology testing market is at the forefront of modern safety assessment, playing a pivotal role in various industries. The in-vitro toxicology testing market is expected to grow at a CAGR of 12% during the forecast period of 2023 to 2031, driven by advancements in products and services, regulatory pressures, and cost-effectiveness. While limitations in replicating complex biological responses remain a restraint, the advantages of in-vitro testing in terms of cost and time efficiency make it a preferred choice for safety assessment. Market segmentation by type and technology highlights specific areas of growth, and geographic trends underscore the significance of regional variations in demand. Competitive players are expected to focus on innovation and diversification to address evolving industry needs and regulatory expectations. The In-vitro Toxicology Testing market is well-positioned to continue shaping the future of safety assessment in various sectors.

Advancements in Product & Service

One of the primary drivers of the In-vitro Toxicology Testing market is the continuous advancement in product and service offerings. The market is witnessing a surge in the development of cutting-edge assays, consumables, equipment, software, and services. The constant evolution of these products and services empowers researchers and organizations to conduct in-vitro toxicology assessments with greater accuracy and efficiency. The introduction of high-throughput technology, sophisticated molecular imaging tools, and comprehensive OMICS technology has revolutionized toxicological testing, facilitating more reliable predictions of substance safety and toxicity.

Regulatory Pressure and Ethical Concerns

The global regulatory landscape has become increasingly stringent, emphasizing the importance of safety evaluations for chemicals and pharmaceuticals. In-vitro toxicology testing plays a pivotal role in addressing these regulatory requirements. Moreover, ethical concerns surrounding animal testing have amplified the demand for in-vitro alternatives. The use of in-vitro methods not only reduces the reliance on animal experimentation but also offers the advantage of quicker, cost-effective, and more humane safety assessments. Stringent regulatory guidelines from global agencies and an increasing number of organizations adopting in-vitro methods as a means of fulfilling ethical responsibilities.

Cost-Effectiveness and Time Efficiency

In-vitro toxicology testing offers substantial cost savings and time efficiency compared to traditional in-vivo testing methods. The conventional method of animal testing is not only expensive but also time-consuming, often resulting in delays in product development. In-vitro testing streamlines the safety assessment process, enabling quicker decision-making and reducing the overall cost of research and development. This economic and time advantage has made in-vitro testing a preferred choice for pharmaceutical companies, chemical manufacturers, and regulatory agencies.

Restraint in the In-vitro Toxicology Testing Market

One of the primary restraints in the In-vitro Toxicology Testing market is the challenge of recreating complex biological responses outside of a living organism. While in-vitro tests have made significant progress in predicting various aspects of toxicity, they still struggle to accurately mimic the intricate interactions that occur within a whole organism. This limitation raises concerns about the potential for false negatives or positives in safety assessments, which can have serious consequences for human health and the environment.

Market Segmentation by Type: Assays Dominate the Market

The In-vitro Toxicology Testing market can be segmented by type into five categories: Product and service, Assays, Consumables, Equipment, Software, and Services. In 2022, Assays generated the highest revenue. These in-vitro testing kits and tools provide precise and targeted information about toxicity, making them indispensable in various industries. For the period from 2023 to 2031, Services are expected to exhibit the highest compound annual growth rate. In-vitro toxicology testing services, including expert consultation, assay development, and data analysis, are anticipated to increase demand as organizations seek specialized assistance for safety assessments.

Market Segmentation by Technology: High Throughput Technology Dominates the Market

The In-vitro Toxicology Testing market can be segmented by technology into four categories: Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology. In 2022, High Throughput Technology generated the highest revenue. This technology enables the rapid screening of a large number of substances, making it a crucial tool for pharmaceutical and chemical industries. For the period from 2023 to 2031, OMICS Technology is expected to experience the highest CAGR. OMICS technology, encompassing genomics, proteomics, and metabolomics, is gaining prominence for its ability to provide comprehensive insights into the effects of substances on biological systems.

North America remains the Global Leader

The In-vitro Toxicology Testing market exhibits geographic variations in demand and growth. Geographic trends indicate that regions with stringent regulatory environments and ethical concerns have a higher demand for in-vitro testing methods. North America, with its well-established pharmaceutical and chemical industries and strict regulatory standards, has been a prominent market for in-vitro toxicology testing. In terms of the region with the highest CAGR during the forecast period from 2023 to 2031, Asia-Pacific is expected to experience substantial growth. The region's expanding pharmaceutical and chemical sectors, coupled with a growing emphasis on regulatory compliance, contribute to its prominence in the market. Regarding revenue percentage, North America is anticipated to maintain its position as the region with the highest revenue percentage throughout the forecast period. The region's investment in research and development and a strong presence of key market players contribute to its substantial market share.

Competitive Trends, Top Players, and Key Strategies

The In-vitro Toxicology Testing market features several key players, including Thermo Fisher Scientific, Charles River Laboratories, Eurofins Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Abbott, Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, and Agilent Technologies. These companies employ specific strategies to maintain and expand their market presence. In 2022, Thermo Fisher Scientific held a significant market share, offering a comprehensive range of in-vitro toxicology testing solutions and services. The company's strategy focused on research and development to introduce innovative assays and testing platforms. Charles River Laboratories, a global leader in contract research services, excelled in providing specialized toxicology testing services. Their strategy emphasized collaboration with pharmaceutical and biotechnology companies to support drug development efforts. Eurofins Scientific, a prominent player in the market, positioned itself as a key provider of in-vitro assays and testing services. Their strategy centered on expanding their portfolio to include the latest technologies and diversifying their offerings. For the forecast period from 2023 to 2031, these companies are expected to continue their strategies, focusing on innovation, specialization, and expanding their service and technology portfolios to meet the evolving needs of the industry and ensure safety assessments of substances.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofIn-Vitro Toxicology Testing market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the In-Vitro Toxicology Testing market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product & Service

  • Consumables
  • Assays
  • Bacterial Toxicity Assays
  • Enzyme Toxicity Assays
  • Cell-based Elisa & Western Blots
  • Receptor-binding Assays
  • Tissue Culture Assays
  • Other Assays
  • Equipment
  • Software
  • Services

Method

  • Cellular Assay
  • Live Cells
  • High Throughput / High Content Screening
  • Molecular Imaging
  • Confocal Microscopy
  • Others
  • Others
  • Fixed Cells
  • Biochemical Assay
  • In-silico
  • Ex-vivo

Technology

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

Toxicity Endpoint & Test

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

End-User

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes & Research Laboratories
  • Diagnostics
  • Chemicals Industry
  • Food Industry

Region Segment

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of In-Vitro Toxicology Testing market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the In-Vitro Toxicology Testing market?
  • Which is the largest regional market for In-Vitro Toxicology Testing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving In-Vitro Toxicology Testing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the In-Vitro Toxicology Testing market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global In-Vitro Toxicology Testing Market
2.2. Global In-Vitro Toxicology Testing Market, By Product & Service, 2022 (US$ Million)
2.3. Global In-Vitro Toxicology Testing Market, By Method, 2022 (US$ Million)
2.4. Global In-Vitro Toxicology Testing Market, By Technology, 2022 (US$ Million)
2.5. Global In-Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2022 (US$ Million)
2.6. Global In-Vitro Toxicology Testing Market, By End-User, 2022 (US$ Million)
2.7. Global In-Vitro Toxicology Testing Market, By Geography, 2022 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2022
3. In-Vitro Toxicology Testing Market: Competitive Analysis
3.1. Market Positioning of Key In-Vitro Toxicology Testing Market Vendors
3.2. Strategies Adopted by In-Vitro Toxicology Testing Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. In-Vitro Toxicology Testing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global In-Vitro Toxicology Testing Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Forces Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Consumables
5.3.2. Assays
5.3.2.1. Bacterial Toxicity Assays
5.3.2.2. Enzyme Toxicity Assays
5.3.2.3. Cell-based Elisa & Western Blots
5.3.2.4. Receptor-binding Assays
5.3.2.5. Tissue Culture Assays
5.3.2.6. Other Assays
5.3.3. Equipment
5.3.4. Software
5.3.5. Services
6. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Cellular Assay
6.3.1.1. Live Cells
6.3.1.2. High Throughput / High Content Screening
6.3.1.3. Molecular Imaging
6.3.1.4. Confocal Microscopy
6.3.1.5. Others
6.3.1.6. Others
6.3.1.7. Fixed Cells
6.3.2. Biochemical Assay
6.3.3. In-silico
6.3.4. Ex-vivo
7. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Cell Culture Technology
7.3.2. High Throughput Technology
7.3.3. Molecular Imaging
7.3.4. OMICS Technology
8. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. ADME
8.3.2. Skin Irritation, Corrosion, & Sensitization
8.3.3. Genotoxicity Testing
8.3.4. Cytotoxicity Testing
8.3.5. Ocular Toxicity
8.3.6. Organ Toxicity
8.3.7. Phototoxicity Testing
8.3.8. Dermal Toxicity
8.3.9. Other Toxicity Endpoints & Tests
9. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2022 Versus 2031
9.3. Market Segmentation
9.3.1. Pharmaceutical Industry
9.3.2. Cosmetics & Household Products
9.3.3. Academic Institutes & Research Laboratories
9.3.4. Diagnostics
9.3.5. Chemicals Industry
9.3.6. Food Industry
10. North America In-Vitro Toxicology Testing Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
10.3. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
10.4. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
10.5. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
10.6. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
10.7. In-Vitro Toxicology Testing Market: By Region, 2021-2031, USD (Million)
10.7.1. North America
10.7.1.1. U.S.
10.7.1.1.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
10.7.1.1.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
10.7.1.1.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
10.7.1.1.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
10.7.1.1.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
10.7.1.2.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
10.7.1.2.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
10.7.1.2.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
10.7.1.2.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
10.7.1.3.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
10.7.1.3.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
10.7.1.3.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
10.7.1.3.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11. UK and European Union In-Vitro Toxicology Testing Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.3. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.4. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.5. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.6. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11.7. In-Vitro Toxicology Testing Market: By Region, 2021-2031, USD (Million)
11.7.1. UK and European Union
11.7.1.1. UK
11.7.1.1.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.1.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.7.1.1.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.7.1.1.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.7.1.1.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.2.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.7.1.2.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.7.1.2.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.7.1.2.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.3.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.7.1.3.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.7.1.3.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.7.1.3.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.4.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.7.1.4.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.7.1.4.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.7.1.4.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11.7.1.5. France
11.7.1.5.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.5.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.7.1.5.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.7.1.5.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.7.1.5.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.6.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
11.7.1.6.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
11.7.1.6.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
11.7.1.6.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12. Asia Pacific In-Vitro Toxicology Testing Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.3. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.4. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.5. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.6. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12.7. In-Vitro Toxicology Testing Market: By Region, 2021-2031, USD (Million)
12.7.1. Asia Pacific
12.7.1.1. China
12.7.1.1.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.1.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.7.1.1.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.7.1.1.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.7.1.1.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.2.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.7.1.2.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.7.1.2.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.7.1.2.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12.7.1.3. India
12.7.1.3.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.3.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.7.1.3.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.7.1.3.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.7.1.3.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.4.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.7.1.4.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.7.1.4.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.7.1.4.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.5.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.7.1.5.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.7.1.5.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.7.1.5.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.6.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
12.7.1.6.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
12.7.1.6.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
12.7.1.6.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
13. Latin America In-Vitro Toxicology Testing Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
13.3. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
13.4. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
13.5. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
13.6. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
13.7. In-Vitro Toxicology Testing Market: By Region, 2021-2031, USD (Million)
13.7.1. Latin America
13.7.1.1. Brazil
13.7.1.1.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
13.7.1.1.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
13.7.1.1.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
13.7.1.1.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
13.7.1.1.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
13.7.1.2.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
13.7.1.2.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
13.7.1.2.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
13.7.1.2.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
13.7.1.3.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
13.7.1.3.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
13.7.1.3.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
13.7.1.3.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
14. Middle East and Africa In-Vitro Toxicology Testing Market, 2021-2031, USD (Million)
14.1. Market Overview
14.2. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
14.3. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
14.4. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
14.5. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
14.6. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
14.7. In-Vitro Toxicology Testing Market: By Region, 2021-2031, USD (Million)
14.7.1. Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
14.7.1.1.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
14.7.1.1.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
14.7.1.1.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
14.7.1.1.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
14.7.1.2.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
14.7.1.2.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
14.7.1.2.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
14.7.1.2.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. In-Vitro Toxicology Testing Market: By Product & Service, 2021-2031, USD (Million)
14.7.1.3.2. In-Vitro Toxicology Testing Market: By Method, 2021-2031, USD (Million)
14.7.1.3.3. In-Vitro Toxicology Testing Market: By Technology, 2021-2031, USD (Million)
14.7.1.3.4. In-Vitro Toxicology Testing Market: By Toxicity Endpoint & Test, 2021-2031, USD (Million)
14.7.1.3.5. In-Vitro Toxicology Testing Market: By End-User, 2021-2031, USD (Million)
15. Company Profile
15.1. Thermo Fisher Scientific
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Charles River Laboratories
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Eurofins Scientific
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Merck KGaA
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. Bio-Rad Laboratories, Inc.
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Abbott, Catalent, Inc.
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. GE Healthcare
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Quest Diagnostics Incorporated
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. Laboratory Corporation of America Holdings
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. Evotec
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Creative Bioarray
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
15.12. Gentronix
15.12.1. Company Overview
15.12.2. Financial Performance
15.12.3. Product Portfolio
15.12.4. Strategic Initiatives
15.13. BioIVT
15.13.1. Company Overview
15.13.2. Financial Performance
15.13.3. Product Portfolio
15.13.4. Strategic Initiatives
15.14. SGS SA
15.14.1. Company Overview
15.14.2. Financial Performance
15.14.3. Product Portfolio
15.14.4. Strategic Initiatives
15.15. Agilent Technologies
15.15.1. Company Overview
15.15.2. Financial Performance
15.15.3. Product Portfolio
15.15.4. Strategic Initiatives
15.16. Other Notable Players
15.16.1. Company Overview
15.16.2. Financial Performance
15.16.3. Product Portfolio
15.16.4. Strategic Initiatives
List of Figures
FIG. 1 Global In-Vitro Toxicology Testing Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global In-Vitro Toxicology Testing Market: Quality Assurance
FIG. 5 Global In-Vitro Toxicology Testing Market, By Product & Service, 2022
FIG. 6 Global In-Vitro Toxicology Testing Market, By Method, 2022
FIG. 7 Global In-Vitro Toxicology Testing Market, By Technology, 2022
FIG. 8 Global In-Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2022
FIG. 9 Global In-Vitro Toxicology Testing Market, By End-User, 2022
FIG. 10 Global In-Vitro Toxicology Testing Market, By Geography, 2022
FIG. 11 Market Geographical Opportunity Matrix - Global In-Vitro Toxicology Testing Market, 2022
FIG. 12 Market Positioning of Key In-Vitro Toxicology Testing Market Players, 2022
FIG. 13 Global In-Vitro Toxicology Testing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
FIG. 14 Global In-Vitro Toxicology Testing Market, By Product & Service, 2022 Vs 2031, %
FIG. 15 Global In-Vitro Toxicology Testing Market, By Method, 2022 Vs 2031, %
FIG. 16 Global In-Vitro Toxicology Testing Market, By Technology, 2022 Vs 2031, %
FIG. 17 Global In-Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2022 Vs 2031, %
FIG. 18 Global In-Vitro Toxicology Testing Market, By End-User, 2022 Vs 2031, %
FIG. 19 U.S. In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 20 Canada In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 21 Rest of North America In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 22 UK In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 23 Germany In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 24 Spain In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 25 Italy In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 26 France In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 27 Rest of Europe In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 28 China In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 29 Japan In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 30 India In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 31 Australia In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 32 South Korea In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 33 Rest of Asia In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 34 Brazil In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 35 Mexico In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 36 Rest of Latin America In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 37 GCC In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 38 Africa In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
FIG. 39 Rest of Middle East and Africa In-Vitro Toxicology Testing Market (US$ Million), 2021-2031
List of Tables
Table 1 Global In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 2 Global In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 3 Global In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 4 Global In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 5 Global In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 6 Global In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 7 Global In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 8 North America In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 9 North America In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 10 North America In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 11 North America In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 12 North America In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 13 North America In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 14 North America In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 15 U.S. In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 16 U.S. In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 17 U.S. In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 18 U.S. In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 19 U.S. In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 20 U.S. In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 21 U.S. In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 22 Canada In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 23 Canada In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 24 Canada In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 25 Canada In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 26 Canada In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 27 Canada In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 28 Canada In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 29 Rest of North America In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 30 Rest of North America In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 31 Rest of North America In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 32 Rest of North America In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 33 Rest of North America In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 34 Rest of North America In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 35 Rest of North America In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 36 UK and European Union In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 37 UK and European Union In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 38 UK and European Union In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 39 UK and European Union In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 40 UK and European Union In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 41 UK and European Union In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 42 UK and European Union In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 43 UK In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 44 UK In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 45 UK In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 46 UK In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 47 UK In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 48 UK In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 49 UK In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 50 Germany In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 51 Germany In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 52 Germany In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 53 Germany In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 54 Germany In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 55 Germany In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 56 Germany In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 57 Spain In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 58 Spain In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 59 Spain In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 60 Spain In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 61 Spain In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 62 Spain In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 63 Spain In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 64 Italy In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 65 Italy In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 66 Italy In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 67 Italy In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 68 Italy In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 69 Italy In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 70 Italy In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 71 France In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 72 France In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 73 France In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 74 France In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 75 France In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 76 France In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 77 France In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 78 Rest of Europe In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 79 Rest of Europe In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 80 Rest of Europe In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 81 Rest of Europe In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 82 Rest of Europe In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 83 Rest of Europe In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 84 Rest of Europe In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 85 Asia In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 86 Asia In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 87 Asia In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 88 Asia In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 89 Asia In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 90 Asia In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 91 Asia In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 92 China In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 93 China In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 94 China In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 95 China In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 96 China In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 97 China In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 98 China In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 99 Japan In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 100 Japan In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 101 Japan In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 102 Japan In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 103 Japan In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 104 Japan In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 105 Japan In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 106 India In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 107 India In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 108 India In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 109 India In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 110 India In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 111 India In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 112 India In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 113 Australia In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 114 Australia In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 115 Australia In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 116 Australia In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 117 Australia In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 118 Australia In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 119 Australia In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 120 South Korea In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 121 South Korea In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 122 South Korea In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 123 South Korea In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 124 South Korea In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 125 South Korea In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 126 South Korea In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 127 Latin America In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 128 Latin America In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 129 Latin America In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 130 Latin America In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 131 Latin America In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 132 Latin America In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 133 Latin America In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 134 Brazil In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 135 Brazil In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 136 Brazil In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 137 Brazil In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 138 Brazil In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 139 Brazil In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 140 Brazil In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 141 Mexico In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 142 Mexico In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 143 Mexico In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 144 Mexico In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 145 Mexico In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 146 Mexico In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 147 Mexico In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 148 Rest of Latin America In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 149 Rest of Latin America In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 150 Rest of Latin America In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 151 Rest of Latin America In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 152 Rest of Latin America In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 153 Rest of Latin America In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 154 Rest of Latin America In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 155 Middle East and Africa In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 156 Middle East and Africa In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 157 Middle East and Africa In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 158 Middle East and Africa In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 159 Middle East and Africa In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 160 Middle East and Africa In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 161 Middle East and Africa In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 162 GCC In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 163 GCC In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 164 GCC In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 165 GCC In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 166 GCC In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 167 GCC In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 168 GCC In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 169 Africa In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 170 Africa In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 171 Africa In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 172 Africa In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 173 Africa In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 174 Africa In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 175 Africa In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)
Table 176 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By Product & Service, 2021-2031, USD (Million)
Table 177 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By Assays, 2021-2031, USD (Million)
TABLE 178 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By Method, 2021-2031, USD (Million)
Table 179 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By Cellular Assay, 2021-2031, USD (Million)
TABLE 180 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By Technology, 2021-2031, USD (Million)
Table 181 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By Toxicity Endpoint & Test, 2021-2031, USD (Million)
Table 182 Rest of Middle East and Africa In-Vitro Toxicology Testing Market By End-User, 2021-2031, USD (Million)

Companies Mentioned

  • Thermo Fisher Scientific
  • Charles River Laboratories
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Abbott, Catalent, Inc.
  • GE Healthcare
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentronix
  • BioIVT
  • SGS SA
  • Agilent Technologies

Related Topics

Related Reports

In Vitro Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

In Vitro Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 170 Pages
  • Global
In-vitro Toxicology Assays Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

In-vitro Toxicology Assays Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
From
in-vitro Toxicology Testing Market Size, Share & Trends Analysis Report by Technology (Cell Culture, High Throughput), End-use, Application, Method (Cellular Assay), Product, Region, and Segment Forecasts, 2024-2030 - Product Image

in-vitro Toxicology Testing Market Size, Share & Trends Analysis Report by Technology (Cell Culture, High Throughput), End-use, Application, Method (Cellular Assay), Product, Region, and Segment Forecasts, 2024-2030

  • Report
  • 117 Pages
  • Global
From
In-Vitro Toxicology Testing Market by Technology, Method, Application, End-User Industry - Global Forecast 2025-2030 - Product Image

In-Vitro Toxicology Testing Market by Technology, Method, Application, End-User Industry - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
in-Vitro Toxicology Testing Global Market Report 2024 - Product Image

in-Vitro Toxicology Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.